SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 325 filers reported holding SEATTLE GENETICS INC in Q2 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $9,119,000 | -2.3% | 46,600 | -15.1% | 0.13% | -4.5% |
| Q2 2020 | $9,329,000 | +95.3% | 54,900 | +32.6% | 0.13% | +41.9% |
| Q1 2020 | $4,777,000 | +11.8% | 41,400 | +10.7% | 0.09% | +36.8% |
| Q4 2019 | $4,273,000 | -38.5% | 37,400 | -54.0% | 0.07% | -47.3% |
| Q3 2019 | $6,943,000 | +37.4% | 81,300 | +11.4% | 0.13% | +50.0% |
| Q2 2019 | $5,052,000 | +50.6% | 73,000 | +59.4% | 0.09% | -53.5% |
| Q1 2019 | $3,354,000 | +69.1% | 45,800 | +30.9% | 0.18% | +42.3% |
| Q4 2018 | $1,983,000 | -45.2% | 35,000 | -25.5% | 0.13% | -43.5% |
| Q3 2018 | $3,621,000 | +10.2% | 46,950 | -5.2% | 0.23% | -17.9% |
| Q2 2018 | $3,286,000 | +28.5% | 49,500 | +1.3% | 0.28% | +10.7% |
| Q1 2018 | $2,557,000 | -10.7% | 48,850 | -8.7% | 0.25% | -15.4% |
| Q4 2017 | $2,862,000 | +16.9% | 53,500 | +18.9% | 0.30% | +16.8% |
| Q3 2017 | $2,448,000 | +21.3% | 45,000 | +15.4% | 0.26% | +7.1% |
| Q2 2017 | $2,018,000 | -17.7% | 39,000 | 0.0% | 0.24% | -26.9% |
| Q1 2017 | $2,452,000 | +8.1% | 39,000 | -9.3% | 0.33% | -29.7% |
| Q4 2016 | $2,269,000 | -2.3% | 43,000 | 0.0% | 0.46% | +10.7% |
| Q3 2016 | $2,322,000 | -15.5% | 43,000 | -36.8% | 0.42% | -18.8% |
| Q2 2016 | $2,748,000 | +15.2% | 68,000 | 0.0% | 0.52% | +19.4% |
| Q1 2016 | $2,386,000 | – | 68,000 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |